Inside This Article: Alabama’s attorney general filed a lawsuit alleging that a medical spa administered non-FDA-approved versions of GLP-1 weight loss drugs without informing patients that the formulations were not authorized. The situation underscores growing concerns as medspas rapidly expand weight loss offerings amid strong consumer demand and uneven regulatory oversight. Allegations involving drug misrepresentation or lack of informed consent can…

